| Product Code: ETC7538446 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Blood Cancer Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Blood Cancer Market Revenues & Volume, 2021 & 2031F |
3.3 India Blood Cancer Market - Industry Life Cycle |
3.4 India Blood Cancer Market - Porter's Five Forces |
3.5 India Blood Cancer Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 India Blood Cancer Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 India Blood Cancer Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.8 India Blood Cancer Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.9 India Blood Cancer Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.10 India Blood Cancer Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.11 India Blood Cancer Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 India Blood Cancer Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of blood cancer cases in India |
4.2.2 Technological advancements in blood cancer treatment options |
4.2.3 Rising awareness and focus on early detection and diagnosis of blood cancer |
4.3 Market Restraints |
4.3.1 High cost of blood cancer treatments and medications |
4.3.2 Limited access to specialized healthcare facilities in certain regions of India |
4.3.3 Stringent regulatory requirements for approval of new blood cancer therapies |
5 India Blood Cancer Market Trends |
6 India Blood Cancer Market, By Types |
6.1 India Blood Cancer Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 India Blood Cancer Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 India Blood Cancer Market Revenues & Volume, By Leukaemia, 2021- 2031F |
6.1.4 India Blood Cancer Market Revenues & Volume, By Lymphoma, 2021- 2031F |
6.1.5 India Blood Cancer Market Revenues & Volume, By Myeloma, 2021- 2031F |
6.2 India Blood Cancer Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 India Blood Cancer Market Revenues & Volume, By Medication, 2021- 2031F |
6.2.3 India Blood Cancer Market Revenues & Volume, By Radiation Therapy, 2021- 2031F |
6.2.4 India Blood Cancer Market Revenues & Volume, By Stem Cell Transplant, 2021- 2031F |
6.2.5 India Blood Cancer Market Revenues & Volume, By Others, 2021- 2031F |
6.3 India Blood Cancer Market, By Diagnosis |
6.3.1 Overview and Analysis |
6.3.2 India Blood Cancer Market Revenues & Volume, By Blood Tests, 2021- 2031F |
6.3.3 India Blood Cancer Market Revenues & Volume, By Bone Marrow Biopsy, 2021- 2031F |
6.3.4 India Blood Cancer Market Revenues & Volume, By Urine Tests, 2021- 2031F |
6.3.5 India Blood Cancer Market Revenues & Volume, By Imaging Tests, 2021- 2031F |
6.4 India Blood Cancer Market, By Dosage Form |
6.4.1 Overview and Analysis |
6.4.2 India Blood Cancer Market Revenues & Volume, By Capsule, 2021- 2031F |
6.4.3 India Blood Cancer Market Revenues & Volume, By Tablets, 2021- 2031F |
6.4.4 India Blood Cancer Market Revenues & Volume, By Injections, 2021- 2031F |
6.4.5 India Blood Cancer Market Revenues & Volume, By Others, 2021- 2031F |
6.5 India Blood Cancer Market, By Route of Administration |
6.5.1 Overview and Analysis |
6.5.2 India Blood Cancer Market Revenues & Volume, By Oral, 2021- 2031F |
6.5.3 India Blood Cancer Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.5.4 India Blood Cancer Market Revenues & Volume, By Others, 2021- 2031F |
6.6 India Blood Cancer Market, By End-Users |
6.6.1 Overview and Analysis |
6.6.2 India Blood Cancer Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 India Blood Cancer Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.6.4 India Blood Cancer Market Revenues & Volume, By Homecare, 2021- 2031F |
6.6.5 India Blood Cancer Market Revenues & Volume, By Others, 2021- 2031F |
6.7 India Blood Cancer Market, By Distribution Channel |
6.7.1 Overview and Analysis |
6.7.2 India Blood Cancer Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.7.3 India Blood Cancer Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.7.4 India Blood Cancer Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 India Blood Cancer Market Revenues & Volume, By Others, 2021- 2031F |
7 India Blood Cancer Market Import-Export Trade Statistics |
7.1 India Blood Cancer Market Export to Major Countries |
7.2 India Blood Cancer Market Imports from Major Countries |
8 India Blood Cancer Market Key Performance Indicators |
8.1 Survival rates of blood cancer patients |
8.2 Adoption rate of advanced blood cancer treatments |
8.3 Number of diagnostic screenings conducted for early detection of blood cancer |
9 India Blood Cancer Market - Opportunity Assessment |
9.1 India Blood Cancer Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 India Blood Cancer Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 India Blood Cancer Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.4 India Blood Cancer Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.5 India Blood Cancer Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.6 India Blood Cancer Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.7 India Blood Cancer Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 India Blood Cancer Market - Competitive Landscape |
10.1 India Blood Cancer Market Revenue Share, By Companies, 2024 |
10.2 India Blood Cancer Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here